aspartic acid has been researched along with nifedipine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Keith, RA; Mangano, TJ; Patel, J; Salama, AI | 1 |
| Bowyer, JF; Weiner, N | 1 |
| Choi, DW; Hartley, DM; Koh, J; Weiss, JH | 1 |
| Orrego, F; Riveros, N | 1 |
| Carter, CJ; Noel, F; Scatton, B | 1 |
| Church, J; Davies, SN; Lodge, D | 1 |
| Hanada, T; Kagaya, T; Katayama, K; Kimura, M; Kuwada, M; Nishizawa, Y; Watanabe, T; Yamanishi, Y | 1 |
| Floersheim, GL | 1 |
| Christopherson, P; Drejer, J; Schousboe, A; Varming, T | 1 |
| Gyte, A; Moores, R; Pitts, M; Smith, JC; Upton, R; Widdowson, PS; Wyatt, I | 1 |
| Evans, GJ; Pocock, JM | 1 |
| Altobelli, D; Fuxe, K; Martire, M; Maurizi, S; Preziosi, P | 1 |
| Bloomfield, SA; Petit-Jacques, J | 1 |
15 other study(ies) available for aspartic acid and nifedipine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Inhibition of K(+)-evoked [3H]D-aspartate release and neuronal calcium influx by verapamil, diltiazem and dextromethorphan: evidence for non-L/non-N voltage-sensitive calcium channels.
Topics: Animals; Aspartic Acid; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Radioisotopes; Cells, Cultured; Cerebral Cortex; Dextromethorphan; Diltiazem; Hippocampus; Male; Neurons; Nifedipine; omega-Conotoxin GVIA; Peptides, Cyclic; Potassium; Rats; Rats, Inbred Strains; Verapamil | 1991 |
Ca2(+)-evoked [3H]dopamine release from synaptosomes is dependent on neuronal type Ca2+ channels and is not mediated by acetylcholine, glutamate or aspartate release.
Topics: Acetylcholine; Animals; Aspartic Acid; Atropine; Brain; Calcium; Calcium Channels; Cobalt; Culture Techniques; Dopamine; Drug Interactions; Ganglionic Blockers; Glutamates; Glutamic Acid; Hexamethonium; Hexamethonium Compounds; Nifedipine; Rats; Synaptosomes; Verapamil | 1990 |
The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Calcium Channels; Drug Antagonism; Ibotenic Acid; In Vitro Techniques; Ion Channel Gating; Kainic Acid; Mice; N-Methylaspartate; Neurons; Nifedipine; Quinolinic Acid; Quinolinic Acids; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1990 |
N-methylaspartate-activated calcium channels in rat brain cortex slices. Effect of calcium channel blockers and of inhibitory and depressant substances.
Topics: Animals; Aspartic Acid; Cadmium; Calcium Channel Blockers; Central Nervous System Depressants; Cerebral Cortex; Cobalt; gamma-Aminobutyric Acid; Ion Channels; Morphine; N-Methylaspartate; Nifedipine; Rats; Tetrodotoxin; Time Factors | 1986 |
Ionic mechanisms implicated in the stimulation of cerebellar cyclic GMP levels by N-methyl-D-aspartate.
Topics: Animals; Aspartic Acid; Calcium; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Female; Male; N-Methylaspartate; Nifedipine; Rats; Zinc | 1987 |
Non-pharmacological effects of the use of microelectrophoresis and pressure ejection of drugs in combination.
Topics: Amino Acids; Animals; Aspartic Acid; Electrophoresis; Ibotenic Acid; Kainic Acid; Microelectrodes; N-Methylaspartate; Neurons; Nifedipine; Oxadiazoles; Quisqualic Acid; Rats; Spinal Cord | 1987 |
Involvement of P-type calcium channels in high potassium-elicited release of neurotransmitters from rat brain slices.
Topics: Analysis of Variance; Animals; Aspartic Acid; Calcium; Calcium Channel Blockers; Calcium Channels; Corpus Striatum; Glutamic Acid; Hippocampus; In Vitro Techniques; Kinetics; Male; Neurotransmitter Agents; Nifedipine; Norepinephrine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptides; Potassium; Rats; Rats, Wistar; Serotonin; Spider Venoms | 1995 |
Radioprotective effects of calcium antagonists used alone or with other types of radioprotectors.
Topics: Animals; Aspartic Acid; Calcium Channel Blockers; Diltiazem; Dimethyl Sulfoxide; Drug Combinations; Female; Flunarizine; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Nifedipine; Nimodipine; Nitrendipine; Radiation-Protective Agents; Verapamil; Zinc | 1993 |
Pharmacological characterisation of voltage-sensitive calcium channels and neurotransmitter release from mouse cerebellar granule cells in culture.
Topics: Animals; Aspartic Acid; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cerebellum; Dose-Response Relationship, Drug; Female; Glutamic Acid; Ion Channel Gating; Mice; Mice, Inbred Strains; Neurons; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Patch-Clamp Techniques; Peptides; Pregnancy; Spider Venoms; Tritium | 1997 |
L-2-chloropropionic acid-induced cerebellar granule cell necrosis is potentiated by L-type calcium channel antagonists.
Topics: Animals; Aspartic Acid; Body Weight; Calcium Channel Blockers; Cerebellar Diseases; Cerebellum; Drug Synergism; Glycine; Hydrocarbons, Chlorinated; Male; Motor Activity; Necrosis; Nifedipine; Propionates; Rats; Sodium; Verapamil | 1997 |
Modulation of neurotransmitter release by dihydropyridine-sensitive calcium channels involves tyrosine phosphorylation.
Topics: Adenosine Triphosphate; Animals; Aspartic Acid; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Adhesion Molecules; Cerebellum; Dihydropyridines; Electrophysiology; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Membrane Potentials; Nerve Tissue Proteins; Nifedipine; omega-Conotoxins; Peptides; Phosphorylation; Potassium; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Time Factors; Tritium; Tyrosine; Vanadates; Vinculin | 1999 |
K(+)-Evoked [(3)H]D-aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists.
Topics: Animals; Aspartic Acid; Baclofen; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Ion Channel Gating; Male; Nerve Endings; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; Peptide Fragments; Potassium; Protein Isoforms; Rats; Rats, Wistar; Spinal Cord; Stereoisomerism; Synaptosomes | 2000 |
Synaptic regulation of the light-dependent oscillatory currents in starburst amacrine cells of the mouse retina.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amacrine Cells; Animals; Aspartic Acid; Biological Clocks; Cadmium Chloride; Calcium Channel Blockers; Electric Stimulation; Excitatory Amino Acid Antagonists; Glycine Agents; In Vitro Techniques; Light; Lysine; Membrane Potentials; Mice; Mice, Inbred C57BL; Nifedipine; Patch-Clamp Techniques; Photic Stimulation; Retina; Strychnine; Synapses | 2008 |